Qorvo's declining ROCE and stagnant capital employed may suggest a mature business facing new competition or smaller margins. Despite concerning fundamentals, the stock's strong performance with a 63% return over the last five years indicates investor optimism. However, these trends may not bode well for long-term performance.
The growth outlook of Qorvo, coupled with its current undervaluation, makes it a potential buy. The undervaluation is attributed not only to its future expectations but also its financial health.
Qorvo executives express confidence in Luxshare's manufacturing competency and anticipate the partnership will help reduce capital intensity, support long-term gross margin objectives, and ensure continuity for their customers in China.
Morning Movers Gapping up $キャリア グローバル(CARR.US)$Shares popped nearly 6% following the announcement that Carrier agreed to sell its Global Access Solutions Business to Honeywell for $4.95 billion in cash.$ハネウェル インターナショナル(HON.US)$'s stock slipped 2.4%. $ファースト ソーラー(FSLR.US)$The solar stock rallied 3.2% after being upgraded to overweight from equal weight by Morgan Stanley. The bank said it sees a number of drivers that can pus...
Qorvo's declining share price and EPS loss depict dwindling investor trust. However, recent sell-off might be a chance considering a long-term growth trend.
Despite the revenue contraction and gross margin decrease, Qorvo's performance is considered strong, with better-than-expected results and strong improvement in inventory levels. However, considering Qorvo's valuation and recent quarter changes, further research is suggested before investing.
Pre-Market Stock Movers Gapping up $モデルナ(MRNA.US)$ (Shares added 1.6% after the biotech company released its second-quarter results. Despite posting a quarterly loss and drop in revenue, Moderna raised its full-year outlook for its Covid vaccine, its only marketable product.) $クォルボ(QRVO.US)$ (The stock rallied 6.8% after the company beat analyst expectations on top and bottom lines in the second quarter. Manage...
Seth Klarman’s 13F portfolio value decreased from $6.13B to $5.85B this quarter. Baupost Group increased Alphabet and Fidelity National Information Services while dropping Meta Platforms, Micron Technology, and Amazon.com. The portfolio continues to be heavily concentrated with the top three positions accounting for ~40% of the 13F portfolio. New Stakes: $スカイワークス ソリューションズ(SWKS.US)$and$ジャズ ファーマシューティカルズ(JAZZ.US)$ Stake Disposals: $メタ プラットフォームズ A(META.US)$ ...
クォルボに関するコメント
Gapping up
$キャリア グローバル(CARR.US)$ Shares popped nearly 6% following the announcement that Carrier agreed to sell its Global Access Solutions Business to Honeywell for $4.95 billion in cash. $ハネウェル インターナショナル(HON.US)$ 's stock slipped 2.4%.
$ファースト ソーラー(FSLR.US)$ The solar stock rallied 3.2% after being upgraded to overweight from equal weight by Morgan Stanley. The bank said it sees a number of drivers that can pus...
$シーラス ロジック(CRUS.US)$ Kioxia Japan $テキサス インスツルメンツ(TXN.US)$ $NXP セミコンダクターズ(NXPI.US)$ $ブロードコム(AVGO.US)$ Skhynix Korea $RENESAS ELECTRONICS CORP(RNECF.US)$ $STマイクロエレクトロニクス(STM.US)$ Bosch $スカイワークス ソリューションズ(SWKS.US)$ $クアルコム(QCOM.US)$ $クォルボ(QRVO.US)$
Gapping up
$モデルナ(MRNA.US)$
(Shares added 1.6% after the biotech company released its second-quarter results. Despite posting a quarterly loss and drop in revenue, Moderna raised its full-year outlook for its Covid vaccine, its only marketable product.)
$クォルボ(QRVO.US)$
(The stock rallied 6.8% after the company beat analyst expectations on top and bottom lines in the second quarter. Manage...
Baupost Group increased Alphabet and Fidelity National Information Services while dropping Meta Platforms, Micron Technology, and Amazon.com.
The portfolio continues to be heavily concentrated with the top three positions accounting for ~40% of the 13F portfolio.
New Stakes:
$スカイワークス ソリューションズ(SWKS.US)$ and $ジャズ ファーマシューティカルズ(JAZZ.US)$
Stake Disposals:
$メタ プラットフォームズ A(META.US)$
...
まだコメントはありません